58 results on '"Pharmaceutical industry -- Health aspects -- Research"'
Search Results
2. Studies from University of Southern California (USC) Further Understanding of COVID-19 (3d-printed Microfluidic Device for High-throughput Production of Lipid Nanoparticles Incorporating Sars-cov-2 Spike Protein Mrna)
3. Study Results from Sante Publique France in the Area of COVID-19 Reported (Protection Against Symptomatic Sars-cov-2 Infection Conferred By the Pfizer-biontech Original/ba.4-5 Bivalent Vaccine Compared To the Mrna Original Monovalent Vaccines - ...)
4. Recent Studies from Pfizer Add New Data to COVID-19 (Effectiveness of Bnt162b2 Ba.4/5 Bivalent Mrna Vaccine Against Symptomatic Covid-19 Among Immunocompetent Individuals Testing At a Large Us Retail Pharmacy)
5. Researchers from Yokohama Municipal Citizen's Hospital Describe Findings in COVID-19 (Early-onset Cervical Myelitis After Covid-19 Vaccination)
6. Studies from Oswaldo Cruz Foundation (FIOCRUZ) Reveal New Findings on COVID-19 (Antibody Response Following the Fourth Sars-cov-2 Vaccine Dose During the Omicron Wave In Brazil)
7. Study finds increased risk of Guillain-Barre after COVID-19 infection
8. Study Data from North Carolina State University (NC State) Update Understanding of COVID-19 (Estimating Vaccine Efficacy Over Time After a Randomized Study Is Unblinded)
9. New Respiratory Tract Infections Study Results Reported from University of California Berkeley (Effectiveness of 13-valent Pneumococcal Conjugate Vaccine Against Medically Attended Lower Respiratory Tract Infection and Pneumonia Among Older ...)
10. Studies from Brigham and Women's Hospital Add New Findings in the Area of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity Among Chimeric Antigen Receptor T Cell Therapy Recipients)
11. Studies in the Area of COVID-19 Reported from Yale University School of Public Health (Infection By Sars-cov-2 With Alternate Frequencies of Mrna Vaccine Boosting)
12. Studies from National Center for Global Health and Medicine Describe New Findings in COVID-19 [Exacerbations of Idiopathic Systemic Capillary Leak Syndrome Following Bnt162b2 Mrna Covid-19 Vaccine (Pfizer-biontech)]
13. Investigators from Johns Hopkins University Have Reported New Data on Vaccine Efficacy [Efficacy of a 4-antigen Staphylococcus Aureus Vaccine In Spinal Surgery: the Staphylococcus Aureus Surgical Inpatient Vaccine Efficacy (Strive) Randomized ...]
14. Research Data from University of Texas Houston Update Understanding of COVID-19 (Covid-19: Perceived Infection Risk and Barriers To Uptake of Pfizer-biontech and Moderna Vaccines Among Community Healthcare Workers)
15. Recent Research from St. George's University of London Highlight Findings in COVID-19 (Maternal Vaccination: a Review of Current Evidence and Recommendations)
16. Study Results from Sanofi in the Area of COVID-19 Reported (A Fluorospot B Assay for the Detection of Iga and Igg Sars-cov-2 Spike-specific Memory B Cells: Optimization and Qualification for Use In Covid-19 Vaccine Trials)
17. Studies in the Area of COVID-19 Reported from Yale University (Age-dependent Impairment In Antibody Responses Elicited By a Homologous Coronavac Booster Dose)
18. Reports from Duke University Advance Knowledge in Cancer Vaccines (Clinical Trials of Self-replicating Rna-based Cancer Vaccines)
19. Research Conducted at Tohoku Medical and Pharmaceutical University Has Updated Our Knowledge about COVID-19 (Progression of Hemolysis In a Patient With Hereditary Spherocytosis After the Second Dose of Covid-19 Mrna Vaccine)
20. Research Conducted at Regeneron Pharmaceuticals Inc. Has Provided New Information about COVID-19 (Efficacy and Safety of a Single Dose of Casirivimab and Imdevimab for the Prevention of Covid-19 Over an 8-month Period: a Randomised, ...)
21. Researchers from King Chulalongkorn Memorial Hospital Report New Studies and Findings in the Area of COVID-19 [Short-term Immune Response After Inactivated Sars-cov-2 (Coronavac?, Sinovac) and Chadox1 Ncov-19 (Vaxzevria?, Oxford-astrazeneca) ...]
22. Study Data from Oita Prefectural Hospital Update Understanding of COVID-19 [Acute Asthma Exacerbation Due To the Sars-cov-2 Vaccine (Pfizer-biontech Bnt162b2 Messenger Rna Covid-19 Vaccine [Comirnaty ®])]
23. Researchers from Medical University of Innsbruck Detail Findings in COVID-19 (Heterologous Chadox1/bnt162b2 Vaccination Induces Stronger Immune Response Than Homologous Chadox1 Vaccination: the Pragmatic, Multi-center, Three-arm, Partially ...)
24. New COVID-19 Findings Reported from Imperial College London (3comparing the Longer-term Effectiveness of a Single Dose of the Pfizer-biontech and Oxford-astrazeneca Covid-19 Vaccines Across the Age Spectrum)
25. New Findings from Jazan University in the Area of COVID-19 Reported [Evaluation of Hematological Parameters and Thrombocytopenia Following Pfizer-biontech (Bnt162b2) Sars-cov-2 Vaccination]
26. New COVID-19 Data Have Been Reported by Investigators at Icahn School of Medicine at Mount Sinai (Comparative Profiles of Sars-cov-2 Spike-specific Human Milk Antibodies Elicited By Mrna- and Adenovirus-based Covid-19 Vaccines)
27. New Findings from Ulster University Update Understanding of COVID-19 (Igg Antibody Production and Persistence To 6 Months Following Sars-cov-2 Vaccination: a Northern Ireland Observational Study)
28. Research Conducted at University College London (UCL) Has Provided New Information about COVID-19 [Neuro-ophthalmic Implications of Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-cov-2) Related Infection and Vaccination]
29. New Findings from University libre of Bruxelles Update Understanding of COVID-19 (Poor Antibody Response To Biontech/pfizer Coronavirus Disease 2019 Vaccination In Severe Acute Respiratory Syndrome Coronavirus 2-naive Residents of Nursing Homes)
30. Study Data from Pfizer Provide New Insights into COVID-19 (safety and Efficacy of a Third Dose of Bnt162b2 Covid-19 Vaccine)
31. Recent Findings from University of Florida Has Provided New Information about COVID-19 (Low-frequency Variants In Mildly Symptomatic Vaccine Breakthrough Infections Presents a Doubled-edged Sword)
32. New COVID-19 Study Results Reported from University of Michigan [Comparative Effectiveness of Coronavirus Disease 2019 (Covid-19) Vaccines Against the Delta Variant]
33. Studies from Michigan Medicine Have Provided New Data on Severe Acute Respiratory Syndrome (Transient Lymphocytic Colitis After Sars-cov2 Mrna Vaccine)
34. Researchers from Department of Research Report Findings in COVID-19 (Effect of Heterologous Vaccination Regimen With Ad5-ncov Cansinobio and Bnt162b2 Pfizer In Sars-cov-2 Igg Antibodies Titers)
35. Research Conducted at AstraZeneca Has Updated Our Knowledge about COVID-19 (The Sars-cov-2 Monoclonal Antibody Combination, Azd7442, Is Protective In Nonhuman Primates and Has an Extended Half-life In Humans)
36. Recent Findings from Regional University Hospital Malaga Provides New Insights into Rheumatic Diseases and Conditions [Position Statement of the Spanish Society of Pediatric Rheumatology On Infection Screening, Prophylaxis, and Vaccination of ...]
37. Studies from University of Toronto Update Current Data on COVID-19 [Differences In Mrna-1273 (Moderna) and Bnt162b2 (Pfizer-biontech) Sars-cov-2 Vaccine Immunogenicity Among Patients Undergoing Dialysis]
38. Studies from Cedars Sinai Medical Center in the Area of COVID-19 Reported [Assessment of Humoral and Cellular Immune Responses To Sars Cov-2 Vaccination (Bnt162b2) In Immunocompromised Renal Allograft Recipients]
39. Pfizer/BioNTech vaccine as booster magnifies antibodies against SARS-CoV-2 by a factor of 25
40. New COVID-19 Findings from Northwestern University Reported (Mrna Intramuscular Vaccination Produces a Robust Igg Antibody Response In Advanced Neuromuscular Disease)
41. Researchers from University of Florida Report New Studies and Findings in the Area of COVID-19 (Finally, an Fda Approval for an Immunization Against Covid-19: Hope On the Horizon)
42. Parental vaccination against coronavirus offers substantial protection to children as well
43. Study finds fewer breakthrough COVID-19 infections, lower risk of hospitalization in those who received Moderna vaccine compared to Pfizer-BioNTech
44. Unique Irish study sheds new light on long-term SARS-CoV-2 vaccine responses in older nursing home residents
45. New COVID-19 Findings Has Been Reported by Investigators at University of Bristol (Effectiveness of Bnt162b2 and Chadox1 Ncov-19 Covid-19 Vaccination At Preventing Hospitalisations In People Aged At Least 80 Years: a Test-negative, Case-control ...)
46. Reports Summarize COVID-19 Study Results from Diaverum (Immunogenicity and Tolerability of Covid-19 Vaccination In Peritoneal Dialysis Patients-a Prospective Observational Cohort Study)
47. Findings from University Hospitals Birmingham in the Area of Severe Acute Respiratory Syndrome Described (Acute-onset Polyradiculoneuropathy After Sars-cov2 Vaccine In the West and North Midlands, United Kingdom)
48. New Findings from Department of Endocrinology and Nutrition Describe Advances in Severe Acute Respiratory Syndrome (Thyroid As a Target of Adjuvant Autoimmunity/inflammatory Syndrome Due To Mrna-based Sars-cov2 Vaccination: From Graves' Disease ...)
49. University of Chicago Reports Findings in COVID-19 [Refractory Vaccine-induced Immune Thrombotic Thrombocytopenia (Vitt) Managed With Delayed Therapeutic Plasma Exchange (Tpe)]
50. Reports from Cornell University Advance Knowledge in COVID-19 (Waning of Bnt162b2 Vaccine Protection Against Sars-cov-2 Infection In Qatar)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.